{"alternate_symbols":[],"keywords":[],"medgen_id":"C2751494","alternate_names":["CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT"],"id":"53833","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017949\"}","{\"db\":\"OMIM\",\"id\":\"104760.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017949\",\"ref_field\":\"name\"}"],"type":"Disease","name":"ABeta amyloidosis, Arctic type"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C3888309","alternate_names":["CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT"],"id":"53837","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017946\"}","{\"db\":\"OMIM\",\"id\":\"104760.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017946\",\"ref_field\":\"name\"}"],"type":"Disease","name":"ABeta amyloidosis, Iowa type"}
{"public_definition":"Mitochondrial complex I deficiency is a shortage (deficiency) of a protein complex called complex I or a loss of its function. Complex I is found in cell structures called mitochondria, which convert the energy from food into a form that cells can use. Complex I is the first of five mitochondrial complexes that carry out a multi-step process called oxidative phosphorylation, through which cells derive much of their energy.Mitochondrial complex I deficiency can cause a wide variety of signs and symptoms affecting many organs and systems of the body, particularly the nervous system, the heart, and the muscles used for movement (skeletal muscles). These signs and symptoms can appear at any time from birth to adulthood.People with mitochondrial complex I deficiency typically have neurological problems, such as abnormal brain function (encephalopathy), recurrent seizures (epilepsy), intellectual disability, difficulty coordinating movements (ataxia), or involuntary movements (dystonia). Affected individuals may have low muscle tone (hypotonia), muscle pain (myalgia), and extreme fatigue in response to physical activity (exercise intolerance). They tend to develop elevated levels of lactic acid in the blood (lactic acidosis), which can cause nausea, vomiting, weakness, and rapid breathing. In severe cases, lactic acidosis can be life-threatening.People with mitochondrial complex I deficiency sometimes have heart, liver, or kidney problems. Vision problems due to abnormal eye movement or breakdown (degeneration) of the nerves that carry signals from the eyes to the brain (optic nerves) can also occur.Some people with mitochondrial complex I deficiency have groups of signs and symptoms that are classified as a specific syndrome. For example, a condition called Leigh syndrome is most commonly caused by mitochondrial complex I deficiency. Leigh syndrome is characterized by progressive loss of mental and movement abilities (developmental or psychomotor regression) and typically results in death within 2 to 3 years from the onset of symptoms. Another condition that can be caused by mitochondrial complex I deficiency, Leber hereditary optic neuropathy, is associated mainly with vision problems due to optic nerve degeneration. These syndromes can also have other causes.","alternate_symbols":[],"keywords":[],"medgen_id":"C1838979","alternate_names":["Complex 1 mitochondrial respiratory chain deficiency","NADH coenzyme Q reductase deficiency"],"id":"3208","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009640\"}","{\"db\":\"Orphanet\",\"id\":\"2609\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+complex+I+deficiency/4823\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mitochondrial-complex-i-deficiency\",\"ref_field\":\"public_definition\"}"],"type":"Disease","name":"Mitochondrial complex I deficiency"}
{"public_definition":"ADCY5 dyskinesia is a hyperkinetic movement disorder (more prominent in the face and arms than the legs) characterized by infantile to late-adolescent onset of chorea, athetosis, dystonia, myoclonus, or a combination of these. To date, affected individuals have had overlapping (but not identical) manifestations with wide-ranging severity. The facial movements are typically periorbital and perioral. The dyskinesia is prone to episodic or paroxysmal exacerbation lasting minutes to hours, and may occur during sleep. Precipitating factors in some persons have included emotional stress, intercurrent illness, sneezing, or caffeine; in others, no precipitating factors have been identified. In some children, severe infantile axial hypotonia results in gross motor delays accompanied by chorea, sometimes with language delays. The overall tendency is for the abnormal movements to stabilize in early middle age, at which point they may improve in some individuals; less commonly, the abnormal movements are slowly progressive, increasing in severity and frequency.","alternate_symbols":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25521004\",\"@Source\":\"PubMed\"},{\"$\":\"NBK263441\",\"@Source\":\"BookShelf\"}]}}","keywords":[],"symbol":"FDFM","medgen_id":"C1847627","alternate_names":["ADCY5-Related Dyskinesia"],"id":"1994","attribute_content":[],"gard_id":"12722","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011707\"}","{\"db\":\"OMIM\",\"id\":\"606703\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324588\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12722\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK263441\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"606703\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Dyskinesia, familial, with facial myokymia"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C0007758","alternate_names":[],"id":"13515","attribute_content":[],"xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001251\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001253\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002513\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007050\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007157\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0000437\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001251\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"85102008\",\"ref_field\":\"name\"}"],"type":"Disease","name":"Cerebellar ataxia"}
{"alternate_symbols":[],"keywords":[],"symbol":"IMD28","medgen_id":"C4013947","alternate_names":["IFNGR2 DEFICIENCY","IMMUNODEFICIENCY 28, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE"],"id":"31853","attribute_content":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"614889\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"319547\"}","{\"db\":\"Orphanet\",\"id\":\"319574\"}","{\"db\":\"OMIM\",\"id\":\"614889\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IFNGR2 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"614889\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 28, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"614889\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Immunodeficiency 28"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C1264041","alternate_names":[],"id":"9627","attribute_content":[],"xrefs":["{\"db\":\"SNOMED CT\",\"id\":\"128108002\",\"ref_field\":\"name\"}"],"type":"Disease","name":"von Willebrand disease type 3"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C4274391","alternate_names":[],"id":"12075","attribute_content":[],"xrefs":[],"type":"Disease","name":"Beta-thalassemia dominant"}
{"alternate_symbols":[],"keywords":[],"symbol":"SPGF35","medgen_id":"C5193038","alternate_names":[],"id":"41426","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032686\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618304.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618304.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618304.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618304.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618341\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"SPERMATOGENIC FAILURE 35"}
{"public_definition":"Bardet-Biedl syndrome is a disorder that affects many parts of the body. The signs and symptoms of this condition vary among affected individuals, even among members of the same family.Vision loss is one of the major features of Bardet-Biedl syndrome. Loss of vision occurs as the light-sensing tissue at the back of the eye (the retina) gradually deteriorates. Problems with night vision become apparent by mid-childhood, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. Most people with Bardet-Biedl syndrome also develop blurred central vision (poor visual acuity) and become legally blind by adolescence or early adulthood.Obesity is another characteristic feature of Bardet-Biedl syndrome. Abnormal weight gain typically begins in early childhood and continues to be an issue throughout life. Complications of obesity can include type 2 diabetes, high blood pressure (hypertension), and abnormally high cholesterol levels (hypercholesterolemia).Other major signs and symptoms of Bardet-Biedl syndrome include the presence of extra fingers or toes (polydactyly), intellectual disability or learning problems, and abnormalities of the genitalia. Most affected males produce reduced amounts of sex hormones (hypogonadism), and they are usually unable to father biological children (infertile). Many people with Bardet-Biedl syndrome also have kidney abnormalities, which can be serious or life-threatening.Additional features of Bardet-Biedl syndrome can include impaired speech, delayed development of motor skills such as standing and walking, behavioral problems such as emotional immaturity and inappropriate outbursts, and clumsiness or poor coordination. Distinctive facial features, dental abnormalities, unusually short or fused fingers or toes, and a partial or complete loss of the sense of smell (anosmia) have also been reported in some people with Bardet-Biedl syndrome. Additionally, this condition can affect the heart, liver, and digestive system.","alternate_symbols":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301537\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1363\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGentest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3061994\",\"@Source\":\"pmc\"}}]}","keywords":[],"symbol":"BBS","medgen_id":"C0752166","alternate_names":[],"id":"376","attribute_content":[],"gard_id":"6866","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0015229\"}","{\"db\":\"OMIM\",\"id\":\"PS209900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"110\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6866\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bardet-Biedl+Syndrome/723\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bardet-biedl-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS209900\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"5619004\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bardet-biedl-syndrome\",\"ref_field\":\"public_definition\"}"],"type":"Disease","name":"Bardet-Biedl syndrome"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C3888308","alternate_names":["CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT"],"id":"53836","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017947\"}","{\"db\":\"OMIM\",\"id\":\"104760.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017947\",\"ref_field\":\"name\"}"],"type":"Disease","name":"ABeta amyloidosis, Italian type"}
{"alternate_symbols":[],"keywords":[],"symbol":"DIGC","medgen_id":"C0345408","alternate_names":["ACROPACHY, HEREDITARY","CLUBBING OF DIGITS"],"id":"1105","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007343\"}","{\"db\":\"OMIM\",\"id\":\"119900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"217059\"}","{\"db\":\"OMIM\",\"id\":\"119900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACROPACHY, HEREDITARY\"}","{\"db\":\"OMIM\",\"id\":\"119900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CLUBBING OF DIGITS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Digital+clubbing%2C+isolated+congenital/8239\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"119900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Digital clubbing, isolated congenital"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C2931672","alternate_names":["AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT","CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT"],"id":"53834","attribute_content":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"104760.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0015033\",\"ref_field\":\"name\"}"],"type":"Disease","name":"ABeta amyloidosis, Dutch type"}
{"alternate_symbols":[],"keywords":[],"medgen_id":"C3888307","alternate_names":["CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT"],"id":"53835","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0017948\"}","{\"db\":\"OMIM\",\"id\":\"104760.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"605714\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017948\",\"ref_field\":\"name\"}"],"type":"Disease","name":"ABetaA21G amyloidosis"}
{"public_definition":"Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of the anterior horn cells in the spinal cord (i.e., lower motor neurons) and the brain stem nuclei. The onset of weakness ranges from before birth to adulthood. The weakness is symmetric, proximal \u003e distal, and progressive. Before the genetic basis of SMA was understood, it was classified into clinical subtypes based on maximum motor function achieved; however, it is now apparent that the phenotype of SMN1-associated SMA spans a continuum without clear delineation of subtypes. With supportive care only, poor weight gain with growth failure, restrictive lung disease, scoliosis, and joint contractures are common complications; however, newly available targeted treatment options are changing the natural history of this disease.","alternate_symbols":["AMC2","AMCN"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301526\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1352\",\"@Source\":\"BookShelf\"}]}}","keywords":[],"medgen_id":"C1859721","alternate_names":["AMC, neurogenic type","Neurogenic type of AMC"],"id":"4619","attribute_content":[],"gard_id":"790","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008823\"}","{\"db\":\"OMIM\",\"id\":\"208100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1143\"}","{\"db\":\"OMIM\",\"id\":\"208100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AMC2\"}","{\"db\":\"OMIM\",\"id\":\"208100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AMCN\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"790\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008823\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1352\",\"ref_field\":\"public_definition\"}"],"type":"Disease","name":"Neurogenic arthrogryposis multiplex congenita"}
{"alternate_symbols":["AMCM"],"keywords":[],"symbol":"AMC3","medgen_id":"C5193121","alternate_names":["ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE"],"id":"42209","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032778\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AMCM\"}","{\"db\":\"OMIM\",\"id\":\"608441.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608441.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608441.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618484\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE"}
{"public_definition":"MEDNIK is a severe multisystem disorder characterized by mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma. It shows phenotypic similarities to CEDNIK (609528) (summary by Montpetit et al., 2008).","alternate_symbols":["EKV3"],"keywords":[],"symbol":"MEDNIK","medgen_id":"C1836330","alternate_names":["ERYTHROKERATODERMIA VARIABILIS, KAMOURASKA TYPE","MEDNIK syndrome"],"id":"2115","attribute_content":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"609313\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"171851\"}","{\"db\":\"OMIM\",\"id\":\"609313\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ERYTHROKERATODERMIA VARIABILIS, KAMOURASKA TYPE\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012251\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEDNIK syndrome\"}","{\"db\":\"OMIM\",\"id\":\"609313\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EKV3\"}","{\"db\":\"OMIM\",\"id\":\"609313\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"609313\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma"}
{"alternate_symbols":["MGA1"],"keywords":[],"symbol":"IGS1","medgen_id":"C4016819","alternate_names":["MEGALOBLASTIC ANEMIA, FINNISH TYPE","Megaloblastic anemia 1, Finnish type"],"id":"10262","attribute_content":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALOBLASTIC ANEMIA, FINNISH TYPE\"}","{\"db\":\"OMIM\",\"id\":\"250950\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGA1\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGA1\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Imerslund-Gr√§sbeck syndrome 1"}
{"alternate_symbols":["NSLH"],"keywords":[],"symbol":"NS/LAH","medgen_id":"C1843181","alternate_names":["MAZZANTI SYNDROME","Noonan-like syndrome with loose anagen hair"],"id":"38380","attribute_content":[],"gard_id":"10719","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011899\"}","{\"db\":\"OMIM\",\"id\":\"PS607721\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2701\"}","{\"db\":\"OMIM\",\"id\":\"607721\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MAZZANTI SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Noonan-like+syndrome+with+loose+anagen+hair/5266\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noonan-like syndrome with loose anagen hair\"}","{\"db\":\"OMIM\",\"id\":\"607721\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSLH\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10719\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"PS607721\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"2701\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"2701\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Noonan syndrome-like disorder with loose anagen hair"}
{"public_definition":"The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delay / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.","alternate_symbols":["SOX2"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301477\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1300\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301552\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1378\",\"@Source\":\"BookShelf\"}]}]}","keywords":[],"symbol":"MCOPS3","medgen_id":"C1859773","alternate_names":["AEG syndrome","Anophthalmia clinical with associated anomalies","Anophthalmia esophageal genital syndrome","Anophthalmia microphthalmia esophageal atresia","Microphthalmia and esophageal atresia syndrome","Microphthalmia syndromic 3","SOX2-Related Eye Disorders"],"id":"5530","attribute_content":[],"gard_id":"1443","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008799\"}","{\"db\":\"OMIM\",\"id\":\"206900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"77298\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microphthalmia+syndromic+3/4787\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Microphthalmia syndromic 3\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1443\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008799\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1300\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"206900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Anophthalmia/microphthalmia-esophageal atresia syndrome"}
{"public_definition":"Mowat-Wilson syndrome (MWS) is characterized by distinctive facial features (widely spaced eyes, broad eyebrows with a medial flare, low-hanging columella, prominent or pointed chin, open-mouth expression, and uplifted earlobes with a central depression), congenital heart defects with predilection for abnormalities of the pulmonary arteries and/or valves, Hirschsprung disease or chronic constipation, genitourinary anomalies (particularly hypospadias in males), and hypogenesis or agenesis of the corpus callosum. Most affected individuals have moderate-to-severe intellectual disability. Speech is typically limited to a few words or is absent, with relative preservation of receptive language skills. Growth restriction with microcephaly and seizure disorder are also common. Most affected people have a happy demeanor and a wide-based gait that can sometimes be confused with Angelman syndrome.","alternate_symbols":["ZEB2"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301585\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1412\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21343952\",\"@Source\":\"PubMed\"}}]}","keywords":[],"symbol":"MOWS","medgen_id":"C1856113","alternate_names":["Hirschsprung disease mental retardation syndrome","Mental retardation, microcephaly, and distinct facial features with or without Hirschsprung disease"],"id":"2968","attribute_content":[],"gard_id":"9673","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009341\"}","{\"db\":\"OMIM\",\"id\":\"235730\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2152\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9673\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mowat-Wilson+syndrome/4895\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mowat-wilson-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1412\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"235730\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Mowat-Wilson syndrome"}
{"public_definition":"ACTG2-related disorders are a subset of visceral myopathy with variable involvement of the bladder and intestine. Bladder involvement can range from neonatal megacystis and megaureter (with its most extreme form of prune belly syndrome) at the more severe end, to recurrent urinary tract infections and bladder dysfunction at the milder end. Chronic bladder dysfunction carries a high risk for urinary tract infections, dilation of the upper urinary tract, and impaired renal function. Intestinal involvement can range from malrotation, neonatal manifestations of microcolon, megacystic microcolon intestinal hypoperistalsis syndrome (MMIHS), and chronic intestinal pseudoobstruction (CIPO) in neonates, children, and adults. Affected infants (with or without evidence of intestinal malrotation) often present with feeding intolerance and findings of non-mechanical bowel obstruction that persist after successful surgical correction of malrotation. Individuals who develop manifestations of CIPO in later childhood or adulthood often experience episodic waxing and waning of bowel motility. They may undergo frequent abdominal surgeries (perhaps related to malrotation or adhesions causing mechanical obstruction) resulting in resection of dilated segments of bowel, often becoming dependent on total parenteral nutrition (TPN).","alternate_symbols":["ACTG2","MFAP5","MMIHS"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"26072522\",\"@Source\":\"PubMed\"},{\"$\":\"NBK299311\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31070878\",\"@Source\":\"PubMed\"},{\"$\":\"NBK540960\",\"@Source\":\"BookShelf\"}]}]}","keywords":[],"symbol":"VSCM","medgen_id":"C0042781","alternate_names":["Berdon syndrome","Infantile visceral myopathy","Megacystis microcolon intestinal hypoperistalsis syndrome","Megacystis, microcolon, hypoperistalsis syndrome","Megaduodenum and/or megacystis","Pseudoobstruction idiopathic intestinal","Visceral myopathy familial"],"id":"2739","attribute_content":[],"xrefs":["{\"db\":\"OMIM\",\"id\":\"155310\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2241\"}","{\"db\":\"Orphanet\",\"id\":\"2604\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Megacystis+microcolon+intestinal+hypoperistalsis+syndrome/4556\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megacystis microcolon intestinal hypoperistalsis syndrome\"}","{\"db\":\"Molecular Diagnostics Laboratory,Hospital Sainte-Justine\",\"id\":\"12-068\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megacystis, microcolon, hypoperistalsis syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Megaduodenum+and-or+megacystis/4557\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megaduodenum and/or megacystis\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK299311\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"155310\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Visceral myopathy"}
{"alternate_symbols":["CMD1N"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301486\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1309\",\"@Source\":\"BookShelf\"}]}}","keywords":[],"symbol":"CMH25","medgen_id":"C4225408","alternate_names":["CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25","Dilated cardiomyopathy 1N"],"id":"4732","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011843\"}","{\"db\":\"OMIM\",\"id\":\"607487\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604488.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25\"}","{\"db\":\"OMIM\",\"id\":\"604488.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25\"}","{\"db\":\"OMIM\",\"id\":\"604488.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25\"}","{\"db\":\"OMIM\",\"id\":\"607487\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dilated+cardiomyopathy+1N/8256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dilated cardiomyopathy 1N\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011843\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607487\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Hypertrophic cardiomyopathy 25"}
{"alternate_symbols":["AMCNMY"],"keywords":[],"symbol":"AMC1","medgen_id":"C4479539","alternate_names":["ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT"],"id":"37798","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0060486\"}","{\"db\":\"OMIM\",\"id\":\"617468\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608303.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"608303.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"608303.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"608303.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"608303.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"608303.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"617468\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"617468\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AMCNMY\"}","{\"db\":\"OMIM\",\"id\":\"617468\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"Arthrogryposis multiplex congenita, neurogenic, with myelin defect"}
{"alternate_symbols":["AMCNACC"],"keywords":[],"symbol":"AMC4","medgen_id":"C5231494","alternate_names":["ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM","ZAIN SYNDROME"],"id":"43487","attribute_content":[],"xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032903\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ZAIN SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AMCNACC\"}","{\"db\":\"OMIM\",\"id\":\"616365.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616365.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618766\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"type":"Disease","name":"ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM"}
{"public_definition":"Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor. Although breast cancer is much more common in women, this form of cancer can also develop in men. In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). In women, cancer can also develop in the glands that produce milk (lobular cancer). Most men have little or no lobular tissue, so lobular cancer in men is very rare.In its early stages, breast cancer usually does not cause pain and may exhibit no noticeable symptoms. As the cancer progresses, signs and symptoms can include a lump or thickening in or near the breast; a change in the size or shape of the breast; nipple discharge, tenderness, or retraction (turning inward); and skin irritation, dimpling, redness, or scaliness. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a person definitely has breast cancer.In some cases, cancerous tumors can invade surrounding tissue and spread to other parts of the body. If breast cancer spreads, cancerous cells most often appear in the bones, liver, lungs, or brain. Tumors that begin at one site and then spread to other areas of the body are called metastatic cancers.A small percentage of all breast cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary breast cancers tend to develop earlier in life than noninherited (sporadic) cases, and new (primary) tumors are more likely to develop in both breasts.","alternate_symbols":[],"content":"{\"Citation\":{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23188549\",\"@Source\":\"PubMed\"}}}","keywords":[],"medgen_id":"C3469522","alternate_names":[],"id":"9673","attribute_content":[],"disease_mechanism":"gain of function","xrefs":["{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000021468\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000210160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325401\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325409\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000326160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508956\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509980\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509985\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512528\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512645\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512816\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520071\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522159\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522161\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525134\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570542\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591268\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"breast-cancer\",\"ref_field\":\"public_definition\"}"],"type":"Disease","disease_mechanism_id":"274","name":"Breast cancer, susceptibility to"}
{"public_definition":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.","alternate_symbols":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301425\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1247\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Stratton and Rahman, 2008\",\"@Type\":\"review\",\"ID\":{\"$\":\"18163131\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17508274\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24366376\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24366402\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24432435\",\"@Source\":\"PubMed\"}}]}","keywords":["Hereditary cancer syndrome","Neoplasm"],"medgen_id":"C0006142","alternate_names":["Breast cancer, familial","CHEK2-Related Breast Cancer"],"id":"536","attribute_content":[],"disease_mechanism":"loss of function","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0016419\"}","{\"db\":\"OMIM\",\"id\":\"114480\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"227535\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530707\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531340\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561700\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591268\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+cancer+of+breast/8375\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254843006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1247\",\"ref_field\":\"public_definition\"}"],"type":"Disease","disease_mechanism_id":"273","name":"Familial cancer of breast"}
{"public_definition":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.","alternate_symbols":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301425\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1247\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACS, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17392385\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20065170\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2003\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"12692171\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Stratton and Rahman, 2008\",\"@Type\":\"review\",\"ID\":{\"$\":\"18163131\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17508274\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19305347\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Phillips et al., 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23918944\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Domchek et al., 2010\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"2948529\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24366376\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23188549\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24366402\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24432435\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"NCCN, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian\"},\"URL\":{\"$\":\"http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf\"}}]}","keywords":[],"symbol":"HBOC","medgen_id":"C0677776","alternate_names":["Hereditary breast and ovarian cancer"],"id":"16761","attribute_content":[],"disease_mechanism":"loss of function","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0003582\"}","{\"db\":\"MeSH\",\"id\":\"D061325\"}","{\"db\":\"OMIM\",\"id\":\"PS604370\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"145\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_4506306\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary breast and ovarian cancer\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000017874\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000017876\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000021468\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000021517\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325401\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325409\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500933\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502103\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503369\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507653\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507764\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508566\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508948\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508956\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509001\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509002\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509978\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509980\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509985\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512699\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512816\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514601\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520071\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520072\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520887\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521499\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521908\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521909\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522159\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522161\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522278\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000523320\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527942\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551440\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551441\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551448\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552302\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558910\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561859\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591268\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"MeSH\",\"id\":\"D061325\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"145\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1247\",\"ref_field\":\"public_definition\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500933\",\"ref_field\":\"symbol\"}"],"type":"Disease","disease_mechanism_id":"273","name":"Hereditary breast and ovarian cancer syndrome"}
{"public_definition":"Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, stomach, ovary, small bowel, hepatobiliary tract, urinary tract, brain, and skin. In individuals with Lynch syndrome the following lifetime risks for cancer are seen: CRC: 52%-82% (mean age at diagnosis 44-61 years). Endometrial cancer in females: 25%-60% (mean age at diagnosis 48-62 years). Gastric cancer: 6%-13% (mean age at diagnosis 56 years). Ovarian cancer: 4%-12% (mean age at diagnosis 42.5 years; ~30% are diagnosed \u003c age 40 years). The risk for other Lynch syndrome-related cancers is lower, though substantially increased over general population rates.","alternate_symbols":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301390\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1211\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EGAPP, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2743612\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCRS, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11598466\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AMA/NCHPEG, 2012\",\"@Type\":\"Suggested Reading\",\"URL\":{\"$\":\"http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25070057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CAPS, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3585492\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25003300\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO/ESMO, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25452455\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mork et al., 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25711197\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Dutch SCG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23535968\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mallorca group, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23408351\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"SGO, 2014\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer\"},\"URL\":{\"$\":\"https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer\"}}]}","keywords":[],"medgen_id":"C4552100","alternate_names":["Familial nonpolyposis colon cancer"],"id":"14688","attribute_content":[],"disease_mechanism":"loss of function","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0005835\"}","{\"db\":\"OMIM\",\"id\":\"PS120435\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"144\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000316595\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321105\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000322202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325623\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332519\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512403\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512828\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515774\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515821\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518997\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518999\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519150\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519254\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520080\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520392\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522224\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522225\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522278\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528914\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529017\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551450\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551459\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551461\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551463\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551464\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552184\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552440\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558908\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561860\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562151\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568362\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568365\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569958\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591173\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591263\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneTests\",\"id\":\"2622\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+Non-Polyposis+Colorectal+Cancer+%28HNPCC%29/3371\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1211\",\"ref_field\":\"public_definition\"}"],"type":"Disease","disease_mechanism_id":"273","name":"Lynch syndrome"}
{"public_definition":"Fabry disease results from deficient activity of the enzyme alpha-galactosidase A (a-Gal A) and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with less than 1% a-Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, they may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, males with greater than 1% a-Gal A activity may have: (1) a cardiac variant phenotype that usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy and arrhythmia, and proteinuria, but without ESRD; or (2) a renal variant phenotype, associated with ESRD but without the skin lesions or pain; or (3) cerebrovascular disease presenting as stroke or transient ischemic attack.","alternate_symbols":[],"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"3009617\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301469\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1292\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"HFSA, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20610207\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12735292\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Eng et al., 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"16980809\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Salviati et al, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2869001\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21934708\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23860966\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","keywords":[],"medgen_id":"C0002986","alternate_names":["Alpha-galactosidase A deficiency","Anderson-Fabry disease","Angiokeratoma corporis diffusum","Angiokeratoma, diffuse","Ceramide trihexosidase deficiency","Ceramide trihexosidosis","Fabry syndrome","Fabry's disease","GLA deficiency","Hereditary dystopic lipidosis"],"id":"1790","attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000514924\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520414\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528516\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551442\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325415\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000512526\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528276\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528500\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528536\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556501\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000505068\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507480\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507942\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000522527\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000246735\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260631\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520063\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520447\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528528\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552214\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000568367\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556520\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000558532\"}]}"],"disease_mechanism":"Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.","gard_id":"6400","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010526\"}","{\"db\":\"OMIM\",\"id\":\"301500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Angiokeratoma corporis diffusum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fabry+Disease/2690\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"16652001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6400\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fabry-disease\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1292\",\"ref_field\":\"public_definition\"}"],"type":"Disease","name":"Fabry disease"}
